← Back to headlines
AstraZeneca Navigates China Challenges Amid New Drug Launches
Pharmaceutical giant AstraZeneca is reportedly facing significant business challenges in China while preparing for key drug launches. Despite these headwinds, two banks are projecting a 20% upside for the company's stock.
10 Apr, 14:31 — 10 Apr, 14:31
Sources
Showing 1 of 1 sources
